Detalhe da pesquisa
1.
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.
Hepatology
; 79(2): 289-306, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540187
2.
Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
BMC Cancer
; 23(1): 1081, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946141
3.
Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC.
Mol Ther
; 27(11): 1906-1918, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31466933
4.
Letter to the editor: the inflamed subclass predicts immunotherapy response - external validations.
Gut
; 2022 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842234
5.
ß-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
Cancer Res
; 84(10): 1643-1658, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417136
6.
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.
Oncogene
; 43(9): 682-692, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216672
7.
Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 2197-2209, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090626
8.
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.
Cell Death Differ
; 30(8): 1931-1942, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419985
9.
GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
Cancer Res
; 82(18): 3223-3235, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895805
10.
Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy.
Front Oncol
; 11: 689068, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34692477
11.
Synthesis and antitumor activity of novel 2',3'-dideoxy-2',3'-diethanethionucleosides bearing 1,2,3-triazole residues.
Bioorg Med Chem Lett
; 20(1): 240-3, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917528
12.
(5S*,6R*,7R*)-6-Formyl-5-phenyl-7-propyl-perhydro-pyrazolo[1,2-a]pyrazol-1-one.
Acta Crystallogr Sect E Struct Rep Online
; 66(Pt 7): o1572, 2010 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21587813
13.
4,5,6-Tri-O-acetyl-2,3-di-S-ethyl-2,3-dithio-d-allose diethyl dithio-acetal.
Acta Crystallogr Sect E Struct Rep Online
; 65(Pt 6): o1227, 2009 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21583095
14.
A novel polyaspartic acid derivative with multifunctional groups for scale inhibition application.
Environ Technol
; 39(7): 843-850, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28355495
15.
The inhibition of PARG attenuates DNA repair in hepatocellular carcinoma.
Mol Biomed
; 4(1): 3, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719492
16.
Near-Infrared Organic Dye-Based Nanoagent for the Photothermal Therapy of Cancer.
ACS Appl Mater Interfaces
; 8(44): 29899-29905, 2016 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27758099
17.
Synthesis and antitumor activity of novel 2',3'-diethanethio-2',3',5'-trideoxy-5'-triazolonucleoside analogues.
Eur J Med Chem
; 45(7): 3219-22, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20409617